| FU Berlin–Agilent: mass spectrometer, 201909 supply existent LC/MS/MS + GC/MS systems at FU Berlin used in doping control study with Agilent support |
2019-09-03 |
| Genedata–Danaher: investment, 202408 acquisition of Genedata that will join Danaher’s Life Science segment |
2024-08-19 |
| GoSilico–Danaher: investment, 202106 acquisition of GoSilico GmbH by Cytiva |
2021-06-02 |
| Gustave Roussy–Biognosys: MS-based proteomics, 202004– collab using proteomic profiling in attempt to repurpose tocilizumab for Covid-19 |
2020-04-28 |
| Helmholtz–Bruker: mass spectrometry software, 201905 supply existent HIPS long-time user of SCiLS Lab + MetaboScape s/w |
2019-05-31 |
| Helmholtz–Bruker: NMR spectrometer, 202009c supply 1.2 GHz NMR spectrometer with 28 Tesla to FZ Jülich |
2020-09-01 |
| Hema.to–SEVERAL: investment, 202306 seed financing round €3.6m with Elaia Partners + Heal Capital + HTGF |
2023-06-26 |
| HexagonFab–Merck (DE): investment, 202412 financing round Series A totalling £6.6m of Abselion incl lead investor M Ventures |
2024-12-04 |
| i3 Membrane–High-Tech Gründerfonds: investment, 202101 financing round totalling 7-figure € sum inkl existing investor HTGF |
2021-01-25 |
| i3 Membrane–OTHER: investment, 202101 financing round totalling 7-figure € sum incl three private investors |
2021-01-25 |
| i3 Membrane–SEVERAL: investment, 202101 financing round 7-figure € sum from HTGF + three private investors |
2021-01-25 |
| Icometrix–Bertarelli Group: investment, 201905 financing round totalling $18m incl new + lead investor Forestay Capital |
2019-05-14 |
| Icometrix–Capricorn Venture Partners: investment, 201905 financing round totalling $18m incl existing + co-investor Capricorn Venture Partners |
2019-05-14 |
| Icometrix–SEVERAL: investment, 201905 financing round $18m led by Forestay Capital + incl Optum Ventures + Capricorn Venture Partners |
2019-05-14 |
| Icometrix–UnitedHealth: investment, 201905 financing round totalling $18m incl new + co-investor Optum Ventures |
2019-05-14 |
| ImaBiotech–Metabrain Research: preclinical research services, 201901– collab strategic partnership ADMET services in preclin metabolic disease models |
2019-01-17 |
| ImaBiotech–OCR (FR): preclinical research services, 201901– collab strategic partnership oncology research in pet tumors using bioanalytical imaging |
2019-01-17 |
| Immunocore–Danaher: data management software, 202409– supply Genedata SDMS for discovery of TCR therapeutics |
2024-09-05 |
| Imprint Analytics–SGS: credit, 201812– convertible loan as part of strategic partnership |
2018-12-12 |
| InDevR–Mérieux: investment, 202301 financing round Series B totalling $9m incl $5m from bioMérieux in connection w partnership |
2023-01-17 |
| Indivumed–Biognosys: MS-based proteomics, 201912– collab integration of HRM MS proteomics data into multi-omics IndivuType cancer database |
2019-12-02 |
| Interherence–Bruker: investment, 202307 acquisition $17.3m of Interherence GmbH by Bruker |
2023-07-03 |
| Invisible Sentinel–Mérieux: investment, 201902 acquisition $75m in cash by bioMérieux |
2019-02-07 |
| Irubis–EU (govt): credit, 202203– convertible loan €500k from EIC Fund as part of EIC Accelerator Pilot programme |
2022-03-24 |
| Irubis–EU (govt): grant, 202005– grant €1.3m from EIC Accelerator Pilot Programme |
2022-05-26 |
| Irubis–EU (govt): investment, 202210 seed financing round totalling €2.8m incl co-investor EIC Fund |
2022-10-06 |
| Irubis–High-Tech Gründerfonds: investment, 202210 seed financing round totalling €2.8m incl co-lead investor HTGF |
2022-10-06 |
| Irubis–OTHER: investment, 202210 seed financing round totalling €2.8m incl business angels as co-investors |
2022-10-06 |
| Irubis–SEVERAL: investment, 202210 seed financing round €2.8m led by HTGF + Verve Ventures + Ventura BioMed Investors |
2022-10-06 |
| Irubis–SEVERAL: investment, 202408 financing round pre-Series A led by new investor BioProcess360 Partners |
2024-08-29 |
| Irubis–TU Munich: investment, 202210 seed financing round totalling €2.8m incl co-investor Initiative for Industrial Innovators |
2022-10-06 |
| Irubis–Ventura Biomed Investors: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Ventura Biomed Investors |
2022-10-06 |
| Irubis–Verve Capital Partners: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Verve Ventures |
2022-10-06 |
| IsoSpec Analytics–Another.vc: investment, 202404 pre-seed financing round totalling $1.9m incl co-investor Another.vc |
2024-04-16 |
| IsoSpec Analytics–Founderful: investment, 202404 pre-seed financing round totalling $1.9m incl lead investor Founderful |
2024-04-16 |
| IsoSpec Analytics–SEVERAL: investment, 202404 pre-seed financing round $1.9m led by Founderful |
2024-04-16 |
| IsoSpec Analytics–Tiny.vc: investment, 202404 pre-seed financing round totalling $1.9m incl co-investor Tiny.vc |
2024-04-16 |
| IsoSpec Analytics–Venture Kick: investment, 202404 pre-seed financing round totalling $1.9m incl co-investor Venture Kick |
2024-04-16 |
| JnJ–Owlstone: breath analyser, 201905– collab developm breath-based test for early detection of pulmonary hypertension with Actelion |
2019-05-20 |
| Knauer–Labomatic Instruments: liquid chromatography 202502– collab strategic combining HPLC offerings to customers incl sales + service |
2025-02-03 |
| Labforward–2mag: investment, 202101 financing round Series B totalling >€5m incl new + co-investor 2mag |
2021-01-11 |
| Labforward–Peppermint: investment, 202101 financing round Series B totalling >€5m incl existing + co-investor Peppermint VenturePartners |
2021-01-11 |
| Labforward–SEVERAL: investment, 202101 financing round Series B >€5m led by Tecan + incl 2mag + Peppermint VenturePartners |
2021-01-11 |
| Labforward–Tecan: investment, 202101 financing round Series B totalling >€5m incl €4m from new + lead investor Tecan resulting in 10% stake |
2021-01-11 |
| Leibniz-Gemeinschaft–Bruker: NRM spectrometer, 202406 supply Avance 1.2 GHz NMR system to FMP Berlin-Buch |
2024-06-30 |
| LemnaTec–Nynomic: investment, 201908 acquisition €na of assets of bankrupt LemnaTec Gmbh by Nynomic AG |
2019-08-12 |
| Lonza–Agilent: analytical instruments, 202112– strategic alliance to integrate analytical technologies in Cocoon cell therapy production platform |
2021-12-15 |
| Lunaphore–Bio-Techne: investment, 202306–202307 acquisition $170.1m of Lunaphore by Bio-Techne |
2023-06-22 |
| Lundbeck–LeadXPro: drug discovery services, 201910– collab structural proteomics services using X-ray + cryo-EM for small molecule drug discovery |
2019-10-07 |
| m2p-labs–Danaher: investment, 202011 acquisition of m2p-biolabs by Beckman Coulter Life Sciences |
2020-11-12 |
| Mainz Biomed–Thermo Fisher: colorectal cancer screening test, 202411– collab developm + commercialisation assays for mRNA-based CRC screening tests |
2024-11-12 |
| Mediaire–High-Tech Gründerfonds: investment, 202012 seed financing round totalling €2m incl investor HTGF |
2020-12-16 |
| Mediaire–LIFTT (IT): investment, 202012 seed financing round totalling €2m incl investor LIFTT SpA |
2020-12-16 |
| Mediaire–PrimeCrowd: investment, 202012 seed financing round totalling €2m incl investor PrimeCrowd |
2020-12-16 |
| Mediaire–SEVERAL: investment, 202012 seed financing round approx €2m incl HTGF + PrimeCrowd + LIFTT |
2020-12-16 |
| Medical Univ South Carolina–Bruker: mass spectrometer, 201905 supply existent timsTOF fleX system early customer Proteomics Center at Med Univ SC |
2019-05-31 |
| Medizinsches Labor Hannover–Labor Limbach: investment, 201901 acquisition 100% of MLH by Limbach Gruppe SE PENDING |
2019-01-26 |
| Merck (DE)–BSSN Software: laboratory software, 2014– supply Merck working with BSSN Software |
2019-08-06 |
| Merck (DE)–Merck (DE): investment, 202112 third increase of financial commitment by €600m in evergreen corporate venture fund M Ventures |
2021-12-08 |
| Merck (DE)–Palantir: data integration and analysis s/w, 201701– collab €na use initially in healthcare ultimately in all 3 business sectors of Merck |
2017-01-12 |
| Merck (DE)–Rigaku: X-ray crystallography, 201906– collab developm of devices for use with Merck consumables using crystalline sponge technology |
2019-06-06 |
| Merck (DE)–Univ Tokyo: crystalline sponge technology, 201906– license for technolgoy invented by Prof Makoto Fujita |
2019-06-06 |
| Mérieux–InDevR: VaxArray platform, 202301– excl distribution of VaxArray portfolio by bioMérieux in Europe |
2023-01-17 |
| Mérieux–JPMorgan Chase: investor conference, 202501 supply service bioMérieux presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| Mérieux–Oxford Nanopore: nanopore technology, 202304– collab strategic exploring nanopore sequencing for infectious disease diagnostics bioMérieux |
2023-04-14 |
| miDiagnostics–Alychlo: investment, 202412 financing round Series D totalling €30m incl existing + co-investor Alychlo |
2024-12-04 |
| miDiagnostics–Pamica: investment, 202412 financing round Series D totalling €30m incl existing + co-investor Pamica |
2024-12-04 |
| miDiagnostics–SEVERAL: investment, 202412 financing round Series D €30m led by Thermo Fisher Scientific |
2024-12-04 |
| miDiagnostics–Thermo Fisher: investment, 202412 financing round Series D totalling €30m incl lead investor Thermo Fisher Scientific |
2024-12-04 |
| miDiagnostics–VMF Invest: investment, 202412 financing round Series D totalling €30m incl existing + co-investor VMF Invest |
2024-12-04 |
| Midwest Biosolutions–Bionter: analytical instruments, 202305– collab Midwest Bio to promote + sell Bionter products + services in the US |
2023-05-08 |
| Miltenyi Biotec–Univ Duisburg-Essen: imaging technology, 201901 acquisition process for opitcal clearing of biological samples for miccrosopy |
2019-01-17 |
| MiniFab–Schott: investment, 201906– acquisition of MiniFab Pty Ltd by Schott |
2019-06-05 |
| MIRO Analytical–Bruker: investment, 202310 majority investment €na by Bruker |
2023-10-04 |
| ModuVision–Knauer: investment, 202206 acquisition of ModuVision by Knauer |
2022-06-13 |
| Molecubes–Bruker: investment, 202111 acquisition $21m by Bruker |
2021-11-19 |
| mzio–Bremen (govt): grant, 202408 grant funding €150k from BAB co-funded by EU |
2024-08-21 |
| NeoSphere Biotechnologies–SEVERAL: investment, 202207 financing round Series A €6m |
2022-07-25 |
| Nion–Bruker: investment, 202401 acquisition $23m of Nion by Bruker |
2024-01-03 |
| NN–Tecan: investment, 201903–201905 acquisition $22.5m in cash of long-term supplier of precision-machined parts w production in California + Vietnam |
2019-03-22 |
| Novalix–Bruker: investment, 202408 strategic minority investment €na by Bruker |
2024-08-07 |
| Novasep–Sartorius: chromatography, 201903– collab developm of systems for membrane chromatography SSB |
2019-03-05 |
| Novasep–Sartorius: investment, 202101– acquisition €na of Novasep’s chromatography process equipment division by Sartorius ANNOUNCED |
2021-01-06 |
| Novasep–Thermo Fisher: investment, 202101 acquisition €725m in cash of viral vector manufacturing business Henogen SA in Belgium by Thermo Fisher |
2021-01-15 |
| Numares–Bruker: NMR spectroscopy, 202102– collab developm + product integration Axinon platform for metabolomics-based NMR-CDx |
2021-01-21 |
| Numares–EU (govt): credit, 202212– quasi-equity venture debt financing up to €20m from EIB |
2022-12-20 |
| Numares–Mayo Clinic: NMR spectroscopy, 201902– collab developm metabolomics-based NMR clinical tests with Mayo Clinic Labs |
2019-02-05 |
| Numares–SEVERAL: investment, 202212 financing round €20m from existing investors |
2022-12-20 |
| Nuvisan–ALS Ltd: investment, 202207 strategic investment acquiring 49% stake in Nuvisan to expand ALS Life Sciences network |
2021-07-28 |
| OHMX.bio–Anacura: investment, 202407 acquisition of OHXM.bio by Anacura |
2024-07-04 |
| OMass–DyNAbind: drug discovery technology, 201905 collab existent with OMass Therapeutics |
2019-05-07 |
| OmicScouts–Momentum Biotechnologies: investment, 202503 acquisition of OmicScouts GmbH by Momentum Biotechnologies |
2025-03-05 |
| Orion Corp–Genedata: bioinformatics, 201909– supply license to Genedata Biologics as SaaS for large-molecule RnD to Orion Pharma |
2019-09-11 |
| Otsuka–LeadXPro: structure-based drug discovery, 201906– collab strategic on membrane protein structure research of Astex + LeadXPro |
2019-06-03 |
| Oxford Nanopore–Mérieux: investment, 202310 investment £69.1m purchase of 29m ordinary shares at £2.38/share by bioMérieux |
2023-10-19 |
| Paramit–Tecan: investment, 202106– acquisition $1b from Altaris Capital Partners LLC ANNOUNCED |
2021-06-23 |
| Plasmion–Bavaria (govt): investment, 201902 financing round totalling almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
| Plasmion–High-Tech Gründerfonds: investment, 201902 financing round totalling almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
| Plasmion–PERSON: investment, 201902 financing round totalling almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
| Plasmion–SEVERAL: investment, 201902 financing round almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
1 2 3 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
